Sex and age differences in atrophic rates

An ADNI study with n=1368 MRI scans

Xue Hua, Derrek P. Hibar, Suh Lee, Arthur W. Toga, Clifford R Jr. Jack, Michael W. Weiner, Paul M. Thompson

Research output: Contribution to journalArticle

80 Citations (Scopus)

Abstract

We set out to determine factors that influence the rate of brain atrophy in 1-year longitudinal magnetic resonance imaging (MRI) data. With tensor-based morphometry (TBM), we mapped the 3-dimensional profile of progressive atrophy in 144 subjects with probable Alzheimer's disease (AD) (age: 76.5 ± 7.4 years), 338 with amnestic mild cognitive impairment (MCI; 76.0 ± 7.2), and 202 healthy controls (77.0 ± 5.1), scanned twice, 1 year apart. Statistical maps revealed significant age and sex differences in atrophic rates. Brain atrophic rates were about 1%-1.5% faster in women than men. Atrophy was faster in younger than older subjects, most prominently in mild cognitive impairment, with a 1% increase in the rates of atrophy and 2% in ventricular expansion, for every 10-year decrease in age. TBM-derived atrophic rates correlated with reduced beta-amyloid and elevated tau levels (n = 363) at baseline, baseline and progressive deterioration in clinical measures, and increasing numbers of risk alleles for the ApoE4 gene. TBM is a sensitive, high-throughput biomarker for tracking disease progression in large imaging studies; sub-analyses focusing on women or younger subjects gave improved sample size requirements for clinical trials.

Original languageEnglish (US)
Pages (from-to)1463-1480
Number of pages18
JournalNeurobiology of Aging
Volume31
Issue number8
DOIs
StatePublished - Aug 2010

Fingerprint

Sex Characteristics
Atrophy
Magnetic Resonance Imaging
Apolipoprotein E4
Brain
Amyloid
Sample Size
Disease Progression
Alzheimer Disease
Biomarkers
Alleles
Clinical Trials
Genes
Cognitive Dysfunction

Keywords

  • Age
  • Alzheimer's disease
  • Atrophy rate
  • Biomarker
  • Drug trial enrichment
  • Longitudinal
  • Mild cognitive impairment
  • MRI
  • Neuroimaging
  • Sex effect
  • Tensor-based morphometry

ASJC Scopus subject areas

  • Aging
  • Developmental Biology
  • Geriatrics and Gerontology
  • Clinical Neurology
  • Neuroscience(all)

Cite this

Sex and age differences in atrophic rates : An ADNI study with n=1368 MRI scans. / Hua, Xue; Hibar, Derrek P.; Lee, Suh; Toga, Arthur W.; Jack, Clifford R Jr.; Weiner, Michael W.; Thompson, Paul M.

In: Neurobiology of Aging, Vol. 31, No. 8, 08.2010, p. 1463-1480.

Research output: Contribution to journalArticle

Hua, Xue ; Hibar, Derrek P. ; Lee, Suh ; Toga, Arthur W. ; Jack, Clifford R Jr. ; Weiner, Michael W. ; Thompson, Paul M. / Sex and age differences in atrophic rates : An ADNI study with n=1368 MRI scans. In: Neurobiology of Aging. 2010 ; Vol. 31, No. 8. pp. 1463-1480.
@article{89d726d95f764f13a25e1aaa1dd02c13,
title = "Sex and age differences in atrophic rates: An ADNI study with n=1368 MRI scans",
abstract = "We set out to determine factors that influence the rate of brain atrophy in 1-year longitudinal magnetic resonance imaging (MRI) data. With tensor-based morphometry (TBM), we mapped the 3-dimensional profile of progressive atrophy in 144 subjects with probable Alzheimer's disease (AD) (age: 76.5 ± 7.4 years), 338 with amnestic mild cognitive impairment (MCI; 76.0 ± 7.2), and 202 healthy controls (77.0 ± 5.1), scanned twice, 1 year apart. Statistical maps revealed significant age and sex differences in atrophic rates. Brain atrophic rates were about 1{\%}-1.5{\%} faster in women than men. Atrophy was faster in younger than older subjects, most prominently in mild cognitive impairment, with a 1{\%} increase in the rates of atrophy and 2{\%} in ventricular expansion, for every 10-year decrease in age. TBM-derived atrophic rates correlated with reduced beta-amyloid and elevated tau levels (n = 363) at baseline, baseline and progressive deterioration in clinical measures, and increasing numbers of risk alleles for the ApoE4 gene. TBM is a sensitive, high-throughput biomarker for tracking disease progression in large imaging studies; sub-analyses focusing on women or younger subjects gave improved sample size requirements for clinical trials.",
keywords = "Age, Alzheimer's disease, Atrophy rate, Biomarker, Drug trial enrichment, Longitudinal, Mild cognitive impairment, MRI, Neuroimaging, Sex effect, Tensor-based morphometry",
author = "Xue Hua and Hibar, {Derrek P.} and Suh Lee and Toga, {Arthur W.} and Jack, {Clifford R Jr.} and Weiner, {Michael W.} and Thompson, {Paul M.}",
year = "2010",
month = "8",
doi = "10.1016/j.neurobiolaging.2010.04.033",
language = "English (US)",
volume = "31",
pages = "1463--1480",
journal = "Neurobiology of Aging",
issn = "0197-4580",
publisher = "Elsevier Inc.",
number = "8",

}

TY - JOUR

T1 - Sex and age differences in atrophic rates

T2 - An ADNI study with n=1368 MRI scans

AU - Hua, Xue

AU - Hibar, Derrek P.

AU - Lee, Suh

AU - Toga, Arthur W.

AU - Jack, Clifford R Jr.

AU - Weiner, Michael W.

AU - Thompson, Paul M.

PY - 2010/8

Y1 - 2010/8

N2 - We set out to determine factors that influence the rate of brain atrophy in 1-year longitudinal magnetic resonance imaging (MRI) data. With tensor-based morphometry (TBM), we mapped the 3-dimensional profile of progressive atrophy in 144 subjects with probable Alzheimer's disease (AD) (age: 76.5 ± 7.4 years), 338 with amnestic mild cognitive impairment (MCI; 76.0 ± 7.2), and 202 healthy controls (77.0 ± 5.1), scanned twice, 1 year apart. Statistical maps revealed significant age and sex differences in atrophic rates. Brain atrophic rates were about 1%-1.5% faster in women than men. Atrophy was faster in younger than older subjects, most prominently in mild cognitive impairment, with a 1% increase in the rates of atrophy and 2% in ventricular expansion, for every 10-year decrease in age. TBM-derived atrophic rates correlated with reduced beta-amyloid and elevated tau levels (n = 363) at baseline, baseline and progressive deterioration in clinical measures, and increasing numbers of risk alleles for the ApoE4 gene. TBM is a sensitive, high-throughput biomarker for tracking disease progression in large imaging studies; sub-analyses focusing on women or younger subjects gave improved sample size requirements for clinical trials.

AB - We set out to determine factors that influence the rate of brain atrophy in 1-year longitudinal magnetic resonance imaging (MRI) data. With tensor-based morphometry (TBM), we mapped the 3-dimensional profile of progressive atrophy in 144 subjects with probable Alzheimer's disease (AD) (age: 76.5 ± 7.4 years), 338 with amnestic mild cognitive impairment (MCI; 76.0 ± 7.2), and 202 healthy controls (77.0 ± 5.1), scanned twice, 1 year apart. Statistical maps revealed significant age and sex differences in atrophic rates. Brain atrophic rates were about 1%-1.5% faster in women than men. Atrophy was faster in younger than older subjects, most prominently in mild cognitive impairment, with a 1% increase in the rates of atrophy and 2% in ventricular expansion, for every 10-year decrease in age. TBM-derived atrophic rates correlated with reduced beta-amyloid and elevated tau levels (n = 363) at baseline, baseline and progressive deterioration in clinical measures, and increasing numbers of risk alleles for the ApoE4 gene. TBM is a sensitive, high-throughput biomarker for tracking disease progression in large imaging studies; sub-analyses focusing on women or younger subjects gave improved sample size requirements for clinical trials.

KW - Age

KW - Alzheimer's disease

KW - Atrophy rate

KW - Biomarker

KW - Drug trial enrichment

KW - Longitudinal

KW - Mild cognitive impairment

KW - MRI

KW - Neuroimaging

KW - Sex effect

KW - Tensor-based morphometry

UR - http://www.scopus.com/inward/record.url?scp=77954007740&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77954007740&partnerID=8YFLogxK

U2 - 10.1016/j.neurobiolaging.2010.04.033

DO - 10.1016/j.neurobiolaging.2010.04.033

M3 - Article

VL - 31

SP - 1463

EP - 1480

JO - Neurobiology of Aging

JF - Neurobiology of Aging

SN - 0197-4580

IS - 8

ER -